Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2444-2449

  Fernando, L P ^a   Fernando, A N ^a   Joseph, K ^a   Kaplan, A P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cytokeratin 1; Endothelial cells; GClqR; High molecular weight kininogen; Proteoglycans

Indexed keywords

ANTIBODY; COMPLEMENT 1Q RECEPTOR; COMPLEMENT RECEPTOR; HEPARAN SULFATE; HEPARIN LYASE; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; KERATIN; MEMBRANE PROTEIN; ZINC;

ARTICLE; CELL CULTURE; CYTOLOGY; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIBODIES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HEPARIN LYASE; HEPARITIN SULFATE; HUMANS; KALLIKREINS; KERATINS; KINETICS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RECEPTORS, COMPLEMENT; UMBILICAL VEINS; ZINC;

EID: 4444273183     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00438.x     Document Type: Article

References (28)

1. Kaplan AP. Initiation of the intrinsic coagulation and fibrinolytic pathways of man. Prog Hemost Thromb 1978; 4: 127-74.
2. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15.
3. Silverberg M, Dunn JT, Garen L, Kaplan AP. Autoactivation of human hageman factor. J Biol Chem 1980; 255: 7281-6.
4. Tankersley DL, Finlayson JS. Kinetics of activation and autoactivation of factor XII. Biochemistry 1984; 23: 273-9.
5. Mandle R Jr, Colman RW, Kaplan AP. Identification of prekallikrein and high molecular weight kininogen as a complex in human plasma. Proc NatlAcad Sci USA 1976; 73: 4179.
6. Herwald H, Dedio J, Kellner R, Loos M, Muller-Esterl W. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. J Biol Chem 1996; 271: 13040-7.
7. Joseph K, Ghebrehiwet B, Peerschke EIB, Reid KBM, Kaplan AP. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII. Identity with the receptor that binds to the globular 'heads' of Clq (gClq-R). Proc Natl Acad Sci USA 1996; 93: 8552-7.
8. Hasan AAK, Zisman T, Schmaier AH. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothe lial cells. Proc Natl Acad Sci USA 1998; 95: 3615-20.
9. Shariat-Madar Z, Mahdi F, Schmaier AH. Mapping binding domains of kininogens on endothelial cell cytokeratin 1. J Biol Chem 1999; 274: 7137-45.
10. Colman RW, Pixley RA, Najamunnisa S, Yan W, Mazar A, McCrae R. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 4 of the urokinase receptor. J Clin Invest 1997; 100: 1481-7.
11. Renne T, Dedio J, David G, Muller-Ester W. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation of endothelial cells. J Biol Chem 2000; 275: 33688-96.
12. Schmaier AH, Kuo A, Lundberg D, Murray S, Cines DB. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 1988; 263: 16327-33.
13. Van Iwaarden F, De Groot PG, Bouma BN. The binding of high molecular weight kininogen to cultured human endothelial cells. J Biol Chem 1988; 263: 4698-703.
14. Reddigari SR, Kuna P, Miragliotta G, Shibayama Y, Nishikawa K, Kaplan AP. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood 1993; 81: 1306-11.
15. Kaplan AP, Joseph K, Sliverberg M. Pathways for bradykinin forma tion and inflammatory disease. J Allergy Clin Immunol 2002; 109: 195-209
16. Peerschke EIB, Smyth SS, Teng El, Dalzell M, Ghebrehiwet B. Human umbilical vein endothelail cells possess binding sites for the gobular head domain of Clq. J Immunol 1996; 157: 4154-8.
17. Jaffe EA. Synthesis of factor VIII by endothelial cells. Ann NY Acad Sci 1982; 401: 163-70.
18. Zhao Y, Qianyao Q, Mahdi F, Shariat-Madar Z, Rojkjaer R, Schmaier AH. Assembly and activation of HK-PK complex on endothelial cell results in bradykinn liberation and NO formation. Am J Physiol 2001; 280: H1821-H1829.
19. Wachtfogel YT, DelaCadenaRA, Kunapuli SP, RickL, MillerM, Schultze RL, Altieri DC, Edgington TS, Colman RW. High molecular weight kininogen binds to MAC-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 1994; 269: 19307-12.
20. Joseph K, Nakazawa Y, Bahou WF, Ghebrehiwet B, Kaplan AP. Platelet glycoprotein lb. A zinc-dependent binding protein for the heavy chain of high molecular weight kininogen. Mol Med 1999; 5: 555-63.
21. Joseph K, Ghebrehiwet B, Kaplan AP. Cytokeratin 1 and gClqR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol 1999; 92: 246-55.
22. Colman RW, Pixley RA, Najamunnisa S, Yan W, Wang J, Mazar A, McCrae KR. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest 1997; 100: 1481-7.
23. Joseph K, Ghebrehiwet B, Kaplan AP. Interaction of high molecular weight kininogen binding proteins with each other. J Thromb Haemost 2001; 86 Suppl.: P2093 (Abstract).
24. Mahdi F, Shariat-Madar Z, Todd RF III, Figueroa CD, Schmaier AH. Expression and colocalization of cytokeratin 1 and urokinase plasmino- gen activator receptor on endothelial cells. Blood 2001; 97: 2342-50.
25. Reddigari SR, Shibayama Y, Brunnee T, Kaplan AP. Human hageman factor (Factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem 1993; 268: 11982-7.
26. Mahdi F, Kuo A, Shariat-Madar Z, Cines DB, Schmaier AH. Mapping the interactions between urokinase plasminogen activator receptor and high molecular weight kininogen. Blood 2002; 100: 71b (Abstract).
27. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VHI-related antigen established by hybridization. Proc NatlAcad Sci USA 1983; 80: 3734-7.
28. Baird TR, Walsh PN. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation. J Biol Chem 2002;227: 38462-7.